USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Mar 9, 2022 | Dec 2021 | $0.10 | - | $-0.74 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Mar 9, 2022 | Dec 2021 | $216.92M | - | $153.54M |
Goodrx's next earnings date is Wednesday, Mar 9, 2022 for the fiscal quarter ending Dec 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 12 | $0.10 | $0.09 | $0.11 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 14 | $0.34 | $0.31 | $0.36 |
| Dec 2022 | 14 | $0.51 | $0.39 | $0.55 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 0 | $0.10 | $0.10 | $0.10 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 0 / 0 | $0.34 | $0.34 | $0.35 |
| Dec 2022 | 0 / 0 | $0.52 | $0.52 | $0.53 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 12 | $216.92M | $209.39M | $225.99M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 15 | $748.29M | $739.99M | $757.30M |
| Dec 2022 | 15 | $1.03B | $937.84M | $1.08B |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 10, 2021 | Sep 2021 | $0.09 | - | - |
| Aug 12, 2021 | Jun 2021 | $0.01 | $0.07 | 407.25% |
| May 13, 2021 | Mar 2021 | $-0.02 | $0.07 | 460.82% |
| Mar 11, 2021 | Dec 2020 | $-0.67 | $-0.74 | -10.15% |
| Nov 12, 2020 | Sep 2020 | $-0.32 | $-0.21 | 34.23% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 11, 2021 | Dec 2020 | $0.35 | $-0.95 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 10, 2021 | Sep 2021 | $194.89M | - | - |
| Aug 12, 2021 | Jun 2021 | $176.63M | $176.63M | 1.00% |
| May 13, 2021 | Mar 2021 | $160.58M | $160.43M | 1.00% |
| Mar 11, 2021 | Dec 2020 | $147.80M | $153.54M | 1.04% |
| Nov 12, 2020 | Sep 2020 | $135.06M | $140.45M | 1.04% |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 11, 2021 | Dec 2020 | $545.07M | $550.70M | 1.03% |
GDRX's next earnings date is Wednesday, Mar 9, 2022 for the fiscal quarter ending Dec 31, 2021.
According to analysts, the average EPS estimation for Goodrx's next quarterly earnings is $0.10, with a low EPS estimation of $0.09, and a high estimation of $0.11.
Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $0.10, the last 2 month trend is $0.10, and the 3 month trend is $0.10.
Based on analysts, the average revenue estimation is $216.92M, with a low revenue estimation of $209.39M, and a high estimation of $225.99M.
Goodrx's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.
Goodrx's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.
GDRX's earnings per share (EPS) was $-0.95, missing the consensus analysts forecast of $0.35 by -371.43%.
Revenues were $550.70M, better than the forecast of $545.07M by 1.03%, and up by 41.85% from previous year's revenue.
The company reported a net income of $-293.62M.
Goodrx reported a free cash flow of $95.52M for its fiscal year, compared to $77.54M a year ago.
The company ended the fiscal year with $671.46M in total debt, a decrease of -0.36% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
